Response of human renal tubular cells to cyclosporine and sirolimus: a toxicogenomic study.

[1]  D. Ron,et al.  The integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage. , 2007, The Journal of clinical investigation.

[2]  E. Neilson,et al.  Chronic kidney disease progression. , 2006, Journal of the American Society of Nephrology : JASN.

[3]  P. Beaune,et al.  Role of P-glycoprotein in cyclosporine cytotoxicity in the cyclosporine-sirolimus interaction. , 2006, Kidney international.

[4]  Luigi Varesio,et al.  Hypoxia Modifies the Transcriptome of Primary Human Monocytes: Modulation of Novel Immune-Related Genes and Identification Of CC-Chemokine Ligand 20 as a New Hypoxia-Inducible Gene1 , 2006, The Journal of Immunology.

[5]  N. Lloberas,et al.  HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. , 2006, Kidney international.

[6]  J. Chapman,et al.  Chronic Allograft Nephropathy: Current Concepts and Future Directions , 2006, Transplantation.

[7]  J. Wetzels,et al.  Sirolimus‐Associated Heavy Proteinuria in a Renal Transplant Recipient: Evidence for a Tubular Mechanism , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  Kebin Hu,et al.  hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists. , 2006, Journal of the American Society of Nephrology : JASN.

[9]  Kebin Hu,et al.  Hepatocyte Growth Factor Is a Downstream Effector that Mediates the Antifibrotic Action of Peroxisome Proliferator–Activated Receptor-γ Agonists , 2005 .

[10]  John Calvin Reed,et al.  Endoplasmic reticulum stress: cell life and death decisions. , 2005, The Journal of clinical investigation.

[11]  Kebin Hu,et al.  Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. , 2005, The American journal of pathology.

[12]  T. McMorrow,et al.  Cyclosporine A induced epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  T. McMorrow,et al.  Cyclosporine A-induced renal fibrosis: a role for epithelial-mesenchymal transition. , 2005, The American journal of pathology.

[14]  P. Beaune,et al.  Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability. , 2005, Kidney international.

[15]  Philip F Halloran,et al.  Immunosuppressive drugs for kidney transplantation. , 2004, The New England journal of medicine.

[16]  S. Head,et al.  De Novo Kidney Transplantation Without Use of Calcineurin Inhibitors Preserves Renal Structure and Function at Two Years , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[17]  J. Chapman,et al.  Calcineurin Inhibitor Nephrotoxicity: Longitudinal Assessment by Protocol Histology , 2004, Transplantation.

[18]  R. Kaufman,et al.  Signaling the Unfolded Protein Response from the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.

[19]  Hong Yi,et al.  Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity. , 2004, Kidney international.

[20]  F. Schena,et al.  Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal. , 2004, Journal of the American Society of Nephrology : JASN.

[21]  Y. Nojima,et al.  Activin A is a potent activator of renal interstitial fibroblasts. , 2004, Journal of the American Society of Nephrology : JASN.

[22]  J. Chapman,et al.  The natural history of chronic allograft nephropathy. , 2003, The New England journal of medicine.

[23]  Terry Speed,et al.  Normalization of cDNA microarray data. , 2003, Methods.

[24]  A. Ruello,et al.  β4 Integrin and Laminin 5 Are Aberrantly Expressed in Polycystic Kidney Disease : Role in Increased Cell Adhesion and Migration , 2003 .

[25]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[26]  A. Ruello,et al.  Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration. , 2003, The American journal of pathology.

[27]  W. Bennett,et al.  Cyclosporine nephrotoxicity. , 2003, Seminars in nephrology.

[28]  Arnold J. Stromberg,et al.  Statistical implications of pooling RNA samples for microarray experiments , 2003, BMC Bioinform..

[29]  D. Ron,et al.  Translational control in the endoplasmic reticulum stress response. , 2002, The Journal of clinical investigation.

[30]  E. Neilson,et al.  Evidence that fibroblasts derive from epithelium during tissue fibrosis. , 2002, The Journal of clinical investigation.

[31]  K. Midtvedt,et al.  Recommendations for the Implementation of Neoral C2 Monitoring in Clinical Practice , 2002, Transplantation.

[32]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[33]  F. Strutz,et al.  Renal fibrosis: an update , 2001, Current opinion in nephrology and hypertension.

[34]  B D Kahan,et al.  Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations. , 2001, Journal of the American Society of Nephrology : JASN.

[35]  A. Macdonald.  A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS , 2001, Transplantation.

[36]  Barry D Kahan,et al.  Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study , 2000, The Lancet.

[37]  J. Campistol,et al.  MECHANISMS OF NEPHROTOXICITY , 2000, Transplantation.

[38]  K. Mori.  Tripartite Management of Unfolded Proteins in the Endoplasmic Reticulum , 2000, Cell.

[39]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[40]  J. Squifflet,et al.  Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients. , 2000, Transplantation.

[41]  Y Chen,et al.  cDNA microarray technology and its applications. , 2000, Biotechnology advances.

[42]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[43]  W. Bennett,et al.  Expression of apoptosis regulatory genes in chronic cyclosporine nephrotoxicity favors apoptosis. , 1999, Kidney international.

[44]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Jaime Prilusky,et al.  GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support , 1998, Bioinform..

[46]  L. Penland,et al.  Use of a cDNA microarray to analyse gene expression patterns in human cancer , 1996, Nature Genetics.

[47]  Y Hochberg,et al.  Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. , 1995, Medical hypotheses.

[48]  L. Fine,et al.  Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: implications for human renal disease progression. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.